Researcher interests: Development of specific immunosuppressive agents. Cancer: mechanisms and treatment. Immune responses - mechanisms and pathways.
FACULTY / SCHOOL: School of Medicine - IMRIC
Contact Business Development: Shani Bullock

Selected Publications

Elisha Solowey, Haya Galski- Lorberboum, Helena Paavilainen, Michal Lichtenstein, Sarah Sallon
Evaluating Medicinal Plants for Anticancer Activity (2014)| Hindawi| Read more
Haya Galski- Lorberboum, Michal Licthenstein, Ofra Sabag, Rotem Kedar
Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment (2012)| Wiley Online Library | Read more
Ann Saada, Haya Galski- Lorberboum, Matan Rapoport, Simon Edvardson
C6ORF66 Is an Assembly Factor of Mitochondrial Complex I (2008)| ScienceDirect | Read more

Contact for more information:

Shani Bullock
VP, Business Development, Healthcare
+972-2-6586608
Contact ME: